Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 8,150 |
| Marketable Securities | 50,760 |
| Other current assets | 1,290 |
| TOTAL | $60,200 |
| Non-Current Assets | |
| PPE Net | 2,690 |
| Other Non-Current Assets | 1,520 |
| TOTAL | $4,210 |
| Total Assets | $62,170 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,300 |
| Accrued Expenses | 3,890 |
| Other current liabilities | 140 |
| TOTAL | $5,930 |
| Non-Current Liabilities | |
| Long Term Debt | 16,870 |
| Other Non-Current Liabilities | 131,580 |
| TOTAL | $148,550 |
| Total Liabilities | $154,500 |
| Shareholders' Equity | |
| Common Shares | 2 |
| Retained earnings | -94,510 |
| Other shareholders' equity | -52 |
| TOTAL | $-92,330 |
| Total Liabilities And Equity | $62,170 |